Mytos (https://www.mytos.bio) develops automated machines that grow human cells for biotech and pharmaceutical companies, aiming to modernize and streamline one of the most manual processes in drug development—cell culture. Their on-premises systems allow organizations to automate the culturing, manipulation, and monitoring of human cells, which are critical for early-stage drug discovery and testing.
For decades, growing cells for research and drug development has been a highly manual, labor-intensive process, largely unchanged for over a century. Mytos addresses this bottleneck by enabling hands-off cell culture: customers can manipulate and monitor their cell batches remotely from the cloud. This automation helps reduce human error, minimize contamination risk, and free up scientist time for higher-value tasks, making research workflows more efficient and scalable.
Mytos primarily serves large pharmaceutical and biotech companies that require reliable, high-throughput cell culture for R&D. By automating routine cell biology tasks, Mytos helps these organizations accelerate drug development timelines and improve experimental consistency.
What technology enables Mytos?
Mytos leverages robotics, advanced sensors, and cloud connectivity to deliver fully automated, on-site cell culture systems. Their machines are designed to seamlessly integrate into existing lab environments, allowing users to schedule, monitor, and adjust cell culture operations remotely. This digital transformation of cell processing marks a significant shift from traditional, manual protocols.
Who are Mytos's competitors?
Mytos operates in the growing cell culture automation market, where several companies provide competing or complementary solutions:
- Formulatrix Cellmatic: Automated cell culture system that feeds, splits, and handles cell lines with minimal manual intervention.
- Molecular Devices CellXpress.ai: AI-powered cell culture management platform for precise scheduling and monitoring.
- Hamilton Company Cell Care STAR: Advanced automated cell culture workstation, focusing on adherent cells and workflow integration.
- Automata: Open, integrated cell biology automation platform designed to reduce manual labor and errors in the lab.
- Retisoft: Flexible automation solutions for various cell culture processes, including seeding, passaging, and harvesting.
- Tecan: Lab automation provider offering modules that automate harvesting, passage, splitting, and seeding of cell cultures.
Each of these competitors brings unique approaches to automating cell biology, with differences in integration, AI capabilities, and target customer segments. Mytos distinguishes itself by focusing on fully hands-off, cloud-connected cell culture machines for on-premises use in demanding biotech and pharma environments.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like Mytos and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.